These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 19027068

  • 1. 17-AAG sensitized malignant glioma cells to death-receptor mediated apoptosis.
    Siegelin MD, Habel A, Gaiser T.
    Neurobiol Dis; 2009 Feb; 33(2):243-9. PubMed ID: 19027068
    [Abstract] [Full Text] [Related]

  • 2. TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin.
    Gaiser T, Becker MR, Habel A, Reuss DE, Ehemann V, Rami A, Siegelin MD.
    Neurosci Lett; 2008 Sep 12; 442(2):109-13. PubMed ID: 18634847
    [Abstract] [Full Text] [Related]

  • 3. Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma.
    Siegelin MD, Habel A, Gaiser T.
    Neurosci Lett; 2008 Dec 19; 448(1):161-5. PubMed ID: 18948169
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
    Georgakis GV, Li Y, Rassidakis GZ, Martinez-Valdez H, Medeiros LJ, Younes A.
    Clin Cancer Res; 2006 Jan 15; 12(2):584-90. PubMed ID: 16428504
    [Abstract] [Full Text] [Related]

  • 5. Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2.
    Siegelin MD, Gaiser T, Habel A, Siegelin Y.
    Neurosci Lett; 2009 May 01; 454(3):223-8. PubMed ID: 19429088
    [Abstract] [Full Text] [Related]

  • 6. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin.
    Son YG, Kim EH, Kim JY, Kim SU, Kwon TK, Yoon AR, Yun CO, Choi KS.
    Cancer Res; 2007 Sep 01; 67(17):8274-84. PubMed ID: 17804742
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genistein enhances proteasomal degradation of the short isoform of FLIP in malignant glioma cells and thereby augments TRAIL-mediated apoptosis.
    Siegelin MD, Siegelin Y, Habel A, Gaiser T.
    Neurosci Lett; 2009 Apr 03; 453(2):92-7. PubMed ID: 19356600
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T.
    Mol Cancer Res; 2008 Dec 03; 6(12):1852-60. PubMed ID: 19074830
    [Abstract] [Full Text] [Related]

  • 14. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS.
    Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319
    [Abstract] [Full Text] [Related]

  • 15. TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions.
    Meurette O, Rebillard A, Huc L, Le Moigne G, Merino D, Micheau O, Lagadic-Gossmann D, Dimanche-Boitrel MT.
    Cancer Res; 2007 Jan 01; 67(1):218-26. PubMed ID: 17210702
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL.
    Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.